Tag Archives: Erika Ebsworth-Goold

Locusts inspire new aerosol-based nanoparticle drug delivery system

Getting medication directly to the brain is a worldwide medical research goal and it seems that a team of scientists at the Washington University at St. Louis (WUSTL) has taken a step forward to accomplishing the goal. From an April 12, 2017 news item on ScienceDaily,

Delivering life-saving drugs directly to the brain in a safe and effective way is a challenge for medical providers. One key reason: the blood-brain barrier, which protects the brain from tissue-specific drug delivery. Methods such as an injection or a pill aren’t as precise or immediate as doctors might prefer, and ensuring delivery right to the brain often requires invasive, risky techniques.

A team of engineers from Washington University in St. Louis has developed a new nanoparticle generation-delivery method that could someday vastly improve drug delivery to the brain, making it as simple as a sniff.

“This would be a nanoparticle nasal spray, and the delivery system could allow a therapeutic dose of medicine to reach the brain within 30 minutes to one hour,” said Ramesh Raliya, research scientist at the School of Engineering & Applied Science.

Caption: Engineers at Washington University have discovered a new technique that could change drug delivery to the brain. They were able to apply a nanoparticle aerosol spray to the antenna of locusts, then track the nanoparticles as they traveled through the olfactory nerves, crossed the blood-brain barrier and accumulated in the brain. This new, non-invasive approach could someday make drug delivery as simple as a sniff for patients with brain injuries or tumors.

Credit: Washington University in St. Louis

An April 12, 2017 WUSTL news release by Erika Ebsworth-Goold (also on EurekAlert), which originated the news item, describes the work in more detail,

“The blood-brain barrier protects the brain from foreign substances in the blood that may injure the brain,” Raliya said. “But when we need to deliver something there, getting through that barrier is difficult and invasive. Our non-invasive technique can deliver drugs via nanoparticles, so there’s less risk and better response times.”

The novel approach is based on aerosol science and engineering principles that allow the generation of monodisperse nanoparticles, which can deposit on upper regions of the nasal cavity via diffusion. Working with Assistant Vice Chancellor Pratim Biswas, chair of the Department of Energy, Environmental & Chemical Engineering and the Lucy & Stanley Lopata Professor, Raliya developed an aerosol consisting of gold nanoparticles of controlled size, shape and surface charge. The nanoparticles were tagged with fluorescent markers, allowing the researchers to track their movement.

Next, Raliya and biomedical engineering postdoctoral fellow Debajit Saha exposed locusts’ antennae to the aerosol, and observed the nanoparticles travel from the antennas up through the olfactory nerves. Due to their tiny size, the nanoparticles passed through the brain-blood barrier, reaching the brain and suffusing it in a matter of minutes.

The team tested the concept in locusts because the blood-brain barriers in the insects and humans have anatomical similarities, and the researchers consider going through the nasal regions to neural pathways as the optimal way to access the brain.

“The shortest and possibly the easiest path to the brain is through your nose,” said Barani Raman, associate professor of biomedical engineering. “Your nose, the olfactory bulb and then olfactory cortex: two relays and you’ve reached the cortex. The same is true for invertebrate olfactory circuitry, although the latter is a relatively simpler system, with supraesophageal ganglion instead of an olfactory bulb and cortex.”

To determine whether or not the foreign nanoparticles disrupted normal brain function, Saha examined the physiological response of olfactory neurons in the locusts before and after the nanoparticle delivery. Several hours after the nanoparticle uptake, no noticeable change in the electrophysiological responses was detected.

“This is only a beginning of a cool set of studies that can be performed to make nanoparticle-based drug delivery approaches more principled,” Raman said.

The next phase of research involves fusing the gold nanoparticles with various medicines, and using ultrasound to target a more precise dose to specific areas of the brain, which would be especially beneficial in brain-tumor cases.

“We want to drug target delivery within the brain using this non-invasive approach,” Raliya said.  “In the case of a brain tumor, we hope to use focused ultrasound so we can guide the particles to collect at that particular point.”

Here’s a link to and a citation for the paper,

Non-invasive aerosol delivery and transport of gold nanoparticles to the brain by Ramesh Raliya, Debajit Saha, Tandeep S. Chadha, Baranidharan Raman, & Pratim Biswas. Scientific Reports 7, Article number: 44718 (2017) doi:10.1038/srep44718 Published online: 16 March 2017

This paper is open access.

I featured another team working on delivering drugs directly to the brain via the olfactory system, except their nanoparticles were gelatin and they were testing stroke medication on rats, in my Sept. 24, 2014 posting.

Eliminate cold storage for diagnostic tests?

There’s a nanoparticle coating that could eliminate the need for cold storage and/or refrigeration for diagnostic testing according to a Jan. 4, 2017 news item on Nanowerk,

Many diagnostic tests use antibodies to help confirm a myriad of medical conditions, from Zika infections to heart ailments and even some forms of cancer. Antibodies capture and help detect proteins, enzymes, bacteria and viruses present in injuries and illnesses, and must be kept at a constant low temperature to ensure their viability — often requiring refrigeration powered by electricity. This can make diagnostic testing in underdeveloped countries, disaster or remote areas and even war zones extremely expensive and difficult.

A team of engineers from Washington University in St. Louis and Air Force Research Laboratory have discovered an inexpensive work-around: a protective coating that could completely eliminate the need for cold storage and change the scope of medical diagnostic testing in places where it’s often needed the most.

“In many developing countries, electricity is not guaranteed,” said Srikanth Singamaneni, associate professor of mechanical engineering and materials science in Engineering & Applied Science at Washington University in St. Louis.

“So how do we best get them medical diagnostics? We did not know how to solve this problem previously.”

A Jan. 4, 2016 Washington University in St. Louis news release by Erika Ebsworth-Goold, which originated the news item, describes how previous research helped lead to a solution,

Singamaneni’s team previously used tiny gold nanorods in bio-diagnostic research, measuring changes in their optical properties to quantify protein concentrations in bio-fluids: the higher a concentration, the higher the likelihood of injury or disease.

In this new research, published in Advanced Materials, Singamaneni worked with faculty from Washington University’s School of Medicine and researchers from the Air Force Research Lab to grow metal-organic frameworks (MOFs) around antibodies attached to gold nanorods. The crystalline MOFs formed a protective layer around the antibodies and prevented them from losing activity at elevated temperatures. The protective effect lasted for a week even when the samples were stored at 60°C.

“This technology would allow point-of-care screening for biomarkers of diseases in urban and rural clinic settings where immediate patient follow-up is critical to treatment and wellbeing,” said Dr. Jeremiah J. Morrissey, professor of anesthesiology, Division of Clinical and Translational Research, Washington University School of Medicine and a co-author on the paper.

“On the spot testing eliminates the time lag in sending blood/urine samples to a central lab for testing and in tracking down patients to discuss test results. In addition, it may reduce costs associated with refrigerated shipping and storage.”

The protective MOF layer can be quickly and easily removed from the antibodies with a simple rinse of slightly acidic water, making a diagnostic strip or paper immediately ready to use. Singamaneni says this proof of concept research is now ready to be tested for clinical samples.

“As long as you are using antibodies, you can use this technology,” said Congzhou Wang, a postdoctoral researcher in Singamaneni’s lab and the paper’s lead author. “In bio-diagnostics from here on out, we will no longer need refrigeration.”

“The MOF-based protection of antibodies on sensor surfaces is ideal for preserving biorecognition abilities of sensors that are designed for deployment in the battlefield,” said Dr. Rajesh R. Naik, 711th Human Performance Wing of the Air Force Research Laboratory, Wright-Patterson Air Force Base, and a co-corresponding author of the paper.  “It provides remarkable stability and extremely easy to remove right before use.”

Here’s a link to and a citation for the paper,

Metal-Organic Framework as a Protective Coating for Biodiagnostic Chips by Congzhou Wang, Sirimuvva Tadepalli, Jingyi Luan, Keng-Ku Liu, Jeremiah J. Morrissey, Evan D. Kharasch, Rajesh R. Naik, and Srikanth Singamaneni. Advanced Materials DOI: 10.1002/adma.201604433 Version of Record online: 7 DEC 2016

© 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim

This paper is behind a paywall.

A final observation, there’s at least one other project aimed at eliminating the need for refrigeration in the field of medical applications and that’s the nanopatch, a replacement for syringes used for liquid medications and vaccines (see my Dec. 16, 2016 posting for a description).